The aim of this study is to characterize the patterns of medication use by early-stage breast cancer (ESBC) survivors from diagnosis to 1 year post-chemotherapy. A single-center longitudinal study was conducted with ESBC patients diagnosed between December 2011 and June 2014.

READ FULL ARTICLE Curated publisher From Springer